TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Freedom from MALE at 6 months plus POD at 30 days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 6-month Tacked segment patency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Probability of nivolumab being cost-effective
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Quality of life related to dysphagia and choking when swallowing
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Stroke volume (SV) decrease
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Shock index increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: ≥50% reduction in pain from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: overall health-promoting lifestyle behaviours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: health responsibility
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lowering periapical PGE2 level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean procedure time
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Reduction in ecchymosis and edema of the eyelids
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Effectiveness of cognitive behavioral therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TPC scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: serum concentration of BDNF
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: serum concentration of VEGF
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of Recovery‐9 item instrument total score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: modified Abdominal and Surgery Impact Scale total score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Deterioration of DVA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: median time of filter life span
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall Summary Score (OSS)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Clinical Summary Score (CSS)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Decline of glycosylated hemoglobin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Proportion of patients with diabetic peripheral neuropathy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: mean composite satisfaction score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: worsened sleep score
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Reduction in total NIH-CPSI score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Responder criterion (decrease of at least 6 points in NIH-CPSI total score)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality-of-life subscore improvement
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in Ritchie's articular index (RAI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in swollen joint count (SJC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in CXCL1 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Time taken for IOL implantation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Nozzle tip damage
Endpoint domain: Adverse events/effects
Primary endpoint: Critical events during IOL delivery
Endpoint domain: Adverse events/effects
Primary endpoint: maximum failure load
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: increase in contact force
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of Life - Physical
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Quality of Life - Social
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Quality of Life - Spiritual
Endpoint domain: Life impact
Endpoint subdomain: null
Primary endpoint: End-stage kidney disease (ESKD) occurrence
Endpoint domain: Mortality/survival
Primary endpoint: Alpha-band activity modulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Mean Index Crown Aesthetic score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: O2 delivery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: EASI head/neck score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: EASI50 and EASI75 scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Bioequivalence of generic Olanzapine to reference formulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma citrulline concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: percentage of CCR9+ Treg cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: plasma sCD14 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: prevalence of VA deficiency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PLSP following surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CCS‐3D Total Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: RBANS Total Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Digit Symbol Coding
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: neurophysiological data improvements
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: postoperative pain duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HCT ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Mean Candida spp. Counts (CFU/ml)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: pruritus control
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative blood transfusion requirements
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Death in hospital
Endpoint domain: Mortality/survival
Primary endpoint: Abdominal pain response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Median number of SUI episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recognition of cardiovascular health risks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Motivation to improve lifestyle
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Acceptability of the MBI program
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: donor intentions
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Prevalence of Gestational Diabetes Mellitus (GDM)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Walking impairment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Alveolar bone height preservation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Alveolar bone width preservation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: KSS scores
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: PVT lapses
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Percentage of correct answers on uterine artery proximity question
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of correct answers on ovarian torsion question
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: insulin total area under the curve
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: blood lipids (triglycerides and non-high-density lipoprotein cholesterol)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: IMB scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Vaccination willingness
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Appointment/vaccination rate
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Incidences of coughing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fluid drainage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Haemoglobin levels in surgical fluid
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Mean AUC for MCI detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: pain reduction after 60 min of drug administration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity to predict viral load > 20 copies/ml
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IHS4-55 score reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Relief of dysmenorrhoea
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean surgery cost
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: composite of cardiovascular death or HF hospitalization
Endpoint domain: Mortality/survival
Primary endpoint: sudden cardiac death or resuscitated cardiac arrest
Endpoint domain: Mortality/survival
Primary endpoint: CRRP (Clinical Remission Rate Percentage)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall health
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: progression of two or more stages of acute kidney injury, death, or dialysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Interdisciplinary education perception
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Teamwork attitudes
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Lean body mass (LBM) maintenance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Enhanced sleep period
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Lower BMI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: COP maximum displacement in anterior-posterior direction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: COP velocity in anterior-posterior direction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: increased eating and acquisition behaviors
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative thirst and hunger
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: decrease in bone mass in the hip
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Complete recovery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Detection of autologous blood transfusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Foot and ankle function and pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Achieving CPREG at M12
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: dose of propofol for insertion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: effective and stable airway management
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean mercury release
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: reduced tension-anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: lower salivary α-amylase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: lower galvanic skin response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of PrEP prescriptions
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: restructuring
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Number of contacts referred per index participant
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: peak ground reaction forces
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: decision errors
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cumulated errors
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increase in cognitive speed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of HSIL+ lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Mean changes from baseline in BCVA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CST and CNV area reductions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time spent in total activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time spent in moderate activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time spent in light activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: resistiveness to care
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: distal interphalangeal joint extension lag
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: pain on the Numeric Pain Rating Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: function according to the brief Michigan Hand Outcome Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: subjective sleep onset latency change from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: subjective sleep efficiency change from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: subjective wake after sleep onset change from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Wound Infections (WIs) rates
Endpoint domain: Adverse events/effects
Primary endpoint: TNF‐α expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: intention to receive HPV vaccination
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: brow suspension
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: anesthetic effect
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Utilization of healthcare providers for SRC-related information
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Trustworthiness of information sources
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: children's speech and language outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: caregivers' empowerment and satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Incidence of investigator-reported respiratory infections
Endpoint domain: Adverse events/effects
Primary endpoint: Smoking use among youth
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: positive fusional vergence (PFV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: near point convergence (NPC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of hypotension events detected
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to detection of the first episode of hypotension
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Need for intensive care unit treatment for newborns
Endpoint domain: Adverse events/effects
Primary endpoint: mean change in percent‐predicted forced vital capacity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: rates of serious adverse events per 100 patient‐years
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of patients with residual neuromuscular blockade
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Symptoms of muscle weakness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Proportion of afebrile children
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Systemic exposure to ciprofloxacin and fluocinolone acetonide
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Insertion ease score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time needed for the procedure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Decreased tearing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: DEQ‐5 score for dry eye severity
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: total daily step count
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: sepsis recurrence
Endpoint domain: Adverse events/effects
Primary endpoint: Spherical Equivalent (SE) measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: NGAL levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: WOMAC pain
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Net total femorotibial joint thickness gain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cognitive function improvement (MMSE, MoCA, MBI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in depression and anxiety (HAMD, HAMA, PSQI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in self-care ability
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: incidence of pin track infection
Endpoint domain: Adverse events/effects
Primary endpoint: time of using antibiotics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: engagement rates
Endpoint domain: Life impact
Endpoint subdomain: null
Primary endpoint: substance use outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: null
Primary endpoint: psychological experiences outcomes
Endpoint domain: Life impact
Endpoint subdomain: emotional functioning/wellbeing
Primary endpoint: Time trial performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Incidence of SARS-CoV-2 positive cases
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Vaccine effectiveness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: multidimensional motor functioning scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: global QoR-40K score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: total hospital stay after surgery
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Freedom from target lesion revascularisation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Percutaneous drain insertion
Endpoint domain: Adverse events/effects
Primary endpoint: Recovery of impedance toward baseline levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neonatal cord blood lead levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Risk of detectable cadmium
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: FMA and BI scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of herpes zoster (HZ)
Endpoint domain: Mortality/survival
Primary endpoint: rehabilitation effect of improved cardiovascular training
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: liver fat content
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SPV variability errors
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the curve (AUC) for risk prediction model
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes